Discover award-winning AI at ECR 2024
Discover award-winning AI at ECR 2024
Annalise Enterprise CXR

AI that empowers clinicians with a second pair of eyes.

Annalise Enterprise CXR

AI that empowers chest X-ray clinicians with a second pair of eyes.

Annalise Triage for chest X-rays

Annalise Triage is U.S. FDA (Food and Drug Administration) cleared for use in triage and notification of pneumothorax, tension pneumothorax, pleural effusion, pneumoperitoneum and vertebral compression fracture on chest X-rays.

Some features are not available in all regions, please check the regulatory status with an Annalise.ai employee.

“Annalise Triage CXR uses deep learning to identify the suspected presence of time-sensitive pathologies and flag priority cases within the radiology worklist, assisting the care team in treating patients with the most critical conditions first. 

Annalise products were designed and built by radiologists, for radiologists, and were trained on some of the largest and most diverse imaging datasets on the planet.”

Rick Abramson, MD 

Chief Medical Officer Annalise.ai 

Highest number of findings
for triage available in the U.S.

Total of five FDA 510(k) cleared findings

Annalise Triage has received a total of five FDA 510(k) cleared findings, and now offers the highest number of findings for triage and notification on chest X-ray in the U.S. market. The findings include: 

  • Pneumothorax  
  • Tension pneumothorax  
  • Pleural effusion  
  • Pneumoperitoneum  
  • Vertebral compression fracture
Worklist prioritization.

Designed to reduce time to action critical findings.

The model analyzes studies as they’re acquired and supplies a notification of urgent cases to a site’s reporting worklist. With integration within PACS, RIS or Reporting Worklist systems, radiologists can more efficiently prioritize their work and report on the most urgent cases first.

Enhanced diagnostic accuracy and confidence

Developed by clinicians for clinicians, our AI decision support solution can detect up to 124 findings on chest X-rays in seconds.

Improves accuracy by 45%, averaged across all analysed findings.

 

We developed our ontology tree to cover the most clinically relevant and helpful findings.

 

“As humans, we can be susceptible to cognitive biases that affect how we look at images, whereas software will look at things objectively every time, so you get a slightly different perspective.

 

Dr Dobb, Consultant in Acute Medicine, Emergency Department, NHS Grampian

Annalise Enterprise CXR

Detect up to 124 findings

on chest X-rays.

A comprehensive decision-support tool developed by clinicians for clinicians. The development of the breadth and depth of Annalise Enterprise CXR’s ontology tree was a clinically driven process, intended to select a comprehensive list of findings that would be most clinically necessary and helpful to clinicians.

 

“As humans, we can be susceptible to cognitive biases that affect how we look at images, whereas software will look at things objectively every time, so you get a slightly different perspective.

 

Dr Dobb, Consultant in Acute Medicine, Emergency Department, NHS Grampian

Annalise Enterprise CXR

Greater productivity.

Improves efficiency by 12%, averaged across all analysed findings.

It empowers busy clinicians to do their best work, especially when they’re under pressure.

“The extra pair of eyes is very welcome. You fatigue a little bit less. And even by the end of a busy ward round you still perform well because you haven’t expended all your energy, concentration and stress levels.

Dr Dobb, Consultant in Acute Medicine, NHS Grampian

Greater productivity, less stress.

Annalise Enterprise CXR improves efficiency by 12% across all 124 findings.

It empowers busy clinicians to do their best work, especially when they’re under pressure.

“Care providers increasingly prefer solutions that can detect multiple anomalies in a single scan, which can reduce image reading time and minimize human error.

Frost & Sullivan, Top Artificial Intelligence Trends Influencing the Future of Radiology, 11 Aug 22

Deliver better care.

Annalise Enterprise CXR assists clinicians to provide the highest standards of care, supporting better patient health outcomes.

“A colleague was initially saying a chest X-ray was normal, but Annalise has flagged it as a potential mass. The patient had a CT scan two days later, which confirmed lung cancer.

Dr Struan Wilkie, Lead Consultant Radiologist, NHS Grampian

Deliver better care.

Annalise Enterprise CXR assists clinicians to provide the highest standards of care, supporting better patient health outcomes.

“In mimicking a radiologist, comprehensive solutions can help avoid missing findings, particularly those that are not part of the primary diagnosis, enabling patients to be put on a treatment pathway for these incidentals as well as primary findings.

Signify Premium Insight: Annalise hoping to get comprehensively ahead. Nov 10, 2022

Intuitive design

See the chest like never before with findings correlated across multiple views.

Analyse up to three images per study.

Results available in less than 20 seconds.

Worklist prioritization.

Designed to reduce time to action critical findings.

The model analyzes studies as they’re acquired and supplies a notification of urgent cases in a site’s reporting worklist. With integration within PACS, RIS or Reporting Worklist systems, radiologists can more efficiently prioritize their work and report on the most urgent cases first.

Intuitively designed

See the chest like never before.

Analysing up to three images per study, including frontal and lateral images, clinicians can see more thanks to the correlation of findings across multiple views.

Worklist prioritization.

Designed to reduce time to action critical findings.

The model analyzes studies as they’re acquired and supplies a notification of urgent cases in a site’s reporting worklist. With integration within PACS, RIS or Reporting Worklist systems, radiologists can more efficiently prioritize their work and report on the most urgent cases first.

Seamless workflow integration

Our customisable user interface can be integrated effortlessly into your PACS and RIS.

Most clinicians feel comfortable using Annalise Enterprise CXR in under 10 studies. To help clinicians interpret with confidence, a confidence bar displays the likelihood of the findings and the AI model’s uncertainty.

Thoughtful design

Flexible user interface (UI), seamless workflow.

Built by clinicians who understand the importance of avoiding disruptions to the workflow, Annalise Enterprise CXR’s customisable UI integrates seamlessly into your PACS and RIS. Most clinicians feel comfortable using Annalise Enterprise CXR in under 10 studies. A confidence bar displays the likelihood of the finding and uncertainty of the AI model assisting clinicians to interpret with confidence.

Powered by clinically robust AI

Broad dataset base. Extensive training. Robust validation.

782,000+

unique CXR studies

Chest X-rays were sourced from broad datasets across three continents – including various types/brands of CXR equipment, departmental and portable imaging, and different patient demographics.

145+

radiologists

Annalise Enterprise CXR has been trained and validated on datasets hand-annotated by at least three individuals from a group of over 145 fully qualified radiologists.

280,000,000+

CXR labels

To ensure a consistent and high standard of annotating across all data-sets, radiologists were trained in standardised annotating procedures.

Annalise Enterprise is intended to assist clinicians with the interpretation of radiological imaging studies. Annalise Enterprise CXR is not available for purchase by the general public. It is available for clinical use in Australia, New Zealand, EU, UK, India, ASEAN*, UAE, more and growing.

For detailed device information, including indications for use, contraindications, and warnings, please consult the user guide prior to use. Not all features are available in all regions. Annalise Enterprise CXR is not for sale in the U.S. Annalise Enterprise CXR is CE marked under Regulation (EU) 2017/745 as a class IIb medical device.

Annalise.ai, ANNALISE ENTERPRISE and the Annalise logo are trademarks of Annalise-AI Pty Ltd, registered in Australia and other countries and regions.

*Annalise Enterprise CXR is not available in all ASEAN countries.

Please reach out to Annalise.ai directly for further information.

Powered by clinically robust AI

Broad set of datasets, extensive training and robust validation.

782,000+

unique CXR studies

Chest X-rays were sourced from broad datasets from three continents – including a variety of CXR machine equipment and manufacturers, departmental and portable imaging, patient demographics, and inpatient and outpatient groups.

145+

radiologists

Annalise Enterprise CXR has been trained and validated on datasets each hand-annotated by at least three fully qualified radiologists out of a group of over 145 radiologists.

280,000,000+

CXR labels

To ensure a consistent and high standard of annotating across all data-sets, radiologists were trained in standardised annotating procedures.

The Annalise Enterprise CXR module is intended to assist clinicians with the interpretation of radiological imaging studies. Annalise Enterprise CXR is not available for purchase by the general public. It is available for clinical use in Australia, New Zealand, EU, UK, India, ASEAN*, UAE, more and growing.  

For detailed device information, including indications for use, contraindications, and warnings, please consult the user guide prior to use. Not all features are available in all regions. Annalise Enterprise CXR is not for sale in the U.S. Annalise Enterprise CXR is CE marked under Regulation (EU) 2017/745 as a class IIb medical device. 

*Annalise Enterprise CXR is not available in all ASEAN countries.

Please reach out to Annalise.ai directly for further information.

From a dataset of 782,000+ CXR Studies

Annotated by 3 radiologists from a pool of >145, who independently hand-annotated each CXR study.

Generating 280,000,000+ CXR labels.

To bring you the quality of Annalise Enterprise CXR Triage

From a dataset of 782,000+ CXR Studies

Annotated by 3 radiologists from a pool of >145, who independently hand-annotated each CXR study.

Generating 280,000,000+ CXR labels.

To bring you the quality of Annalise Enterprise CXR Triage

All FDA-cleared Annalise CXR findings are a subset of a comprehensive group of findings, validated and available for clinical use outside the U.S., with clinical studies showing improvements in detection accuracy, diagnostic decision-making, and reporting speed. See the Evidence.

Annalise Enterprise is not available for purchase by the general public. Always follow the directions for use.  

Not all features are available in all regions, please reach out to Annalise.ai directly for further information.  

Drafting the future of radiology with
Annalise Reporting!

Annalise Enterprise CXR  is now available with our automated draft reporting feature.

Designed to make radiology reporting quick and easy, Annalise Reporting creates complete, editable draft reports ready for radiologists to review and sign off.

Annalise Reporting is fully integrated into routine reporting workflow and backed by the comprehensive set of findings built into Annalise solutions.

Drafting the future of radiology with
Annalise Reporting!

Annalise Enterprise CXR  is now available with our automated draft reporting feature.

Designed to make radiology reporting quick and easy, Annalise Reporting creates complete, editable draft reports ready for radiologists to review and sign off.

Annalise Reporting is fully integrated into routine reporting workflow and backed by the comprehensive set of findings built into Annalise solutions.

Discover Annalise Products

Contact us to request a brochure, private demonstration or with any questions you may have.


Warning: Undefined array key "country_code" in /www/annalise_914/public/wp-content/themes/annalise/footer.php on line 154